Updated but hopefully obsolete (in a positive way) by the

New Post Public Reply Private Reply Replies (0) Message Board
blafarm
674
Updated but hopefully obsolete (in a positive way) by the end of the week.


Potential Catalysts w/ Est. Dates 8-19-2020

- US COVID P2 M/M FDA EUA Unmet Need Response – ?
- US COVID P2 M/M EU, Philippines, Israel Submissions – ?
- US COVID P2 M/M Journal Article by Trial Doctors – ?

- US COVID P3 S/C Interim Enrollment (195) – September 1
- US COVID P3 S/C Interim 28-Day Completion – September 28
- US COVID P3 S/C Interim Results (2-Weeks) – Mid October
- US COVID P3 S/C FDA EUA Submission – ?

COVID NOTES:
The FDA may demand a Phase 3 Registrational for M/M
The FDA may demand full completion of Phase 3 S/C

- Dr. Patterson Paper Peer Reviewed – Soon

- FDA HIV Combo BLA Type A Meeting (w/Mono Guidance) – ?

- Samsung Biologics Shipment Update – August/September
- Science Advisory Board Update PR – August/September
- Mainstream Media Update – August/September

- US COVID OWS / Funding / Grants Update – August/September
- Investment Bank Update – August/September
- IncellDx Companion Assays Update – August/September

- UK COVID Trial Update – ?
- UK Combo HIV Pre-BLA Meeting – ?
- Brazil COVID Trial Update – ?
- Other Countries Express Interest – ?

- Worldwide Pharma (5) License/Partnership Update – August/September
- Regional Pharma License/Partnership Update: Brazil, China, India, Europe, Middle East, Northern Africa – August/September

- NASDAQ Uplist Est. Date – August 22 (+/-)
- Larger Capital Raise After Uplist – ?

- Combo HIV BLA Re-Submission (w/Mono?) – ?

- US BTD Cancer Meeting: mTNBC + Basket 22 – September

- Dr. Seethamraju Paper - 11-Patients – ?
- Dr. Yang Paper - 29-Patients – ?
- Dr. Agresti Paper - 4-Patients – ?

- mTNBC Trial Update – ?
- Cancer Basket 22 Trial Update – ?
- MS Trial Update – ?
- NASH Trial Update – 1st Patient September ?
- GvHD Trial Update – ?
- Alzheimer’s Trial Update – ?
- HIV Cure Trial Update – ?
- Taiwan Cancer Basket Trial Update – ?

- US Combo HIV FDA Approval (Mono?) – ?

- HIV PrEP OHSU/Sacha Animal Study Completion – August 2025


Potential Additional Trials for 2020:

Phase 2:

- Influenza
- Stroke
- Septic Shock
- IBS Inflammatory Bowel Syndrome
- Psoriasis
- Autoimmune Hepatitis

Phase 3:

- US COVID PrEP
- US COVID Long Haul
- HIV Mono Therapy


Completed Catalysts
- Dr.BP Manuscript Pre-print
- US COVID Pediatric Protocol
- NEJM Submissions Amarex Montefiore / Georgia
- US COVID Distribution Agreement
- Dr. Sacha HIV PrEP Presentation
- Small Capital Raise Before Uplist
- US COVID P2 M/M Top Line Efficacy Results
- US COVID P2 M/M FDA EUA Unmet Need Submission – August 12
- SEC 10k & Audited Financials Complete – August 17
- US COVID P2 M/M Mexico Submission – August 17
- US COVID P2 M/M UK Fast Track Submission – August 19

Back-Burner Catalysts
- Dr.BP Manuscript #2 Pre-Print
- Dr.BP Manuscript #2 Peer Review
- Dr.BP Infectious Virus in Plasma
- Dr.BP Rantes Susceptibility Testing Program
- Commercialization Officer Full-Time Hire

Rejected Catalysts
- US COVID Emergency eIND
- US COVID Compassionate Use Pre-July
- Mexico COVID Combo Trial
- US COVID P3 Remdesivir 3-Arm Trial




CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Low GWP Refrigerants: Potential $13B Market by 2031

Updated Category News Views 2

Refrigerants: They're Hot in More Ways Than One Who would've thought refrigerants could be such a big deal? But here we are. The low global warming potential (GWP) refrigerants market is heating up, projected to jump from $8.17 billion in 2026 to a whopping $13.06 billion by 2031. That's a solid 9.8% CAGR if you're keeping score. The drivers? Well, we’ve got...

Continue Reading
LifeWave's Bold New Path in Human Performance

Updated Category News Views 4

Redefining the Everyday Athlete Not every day you see a wellness company talking about 'performance' in the broader human sense. Not just for the pros or those beating personal records but for anyone looking to lift the quality of their daily grind. That's the new line LifeWave's drawing in the sand with their spiffy 'Human Performance Technology.' They're looking to...

Continue Reading
Voter Power Flexes with Early Voting Celebrations

Updated Category News Views 9

Voter Engagement Hits a New High with Nationwide Parties Well, look at that—voter turnout's got its own party scene now, and it's making waves. As Vote Early Day approaches, the folks at When We All Vote are cranking up the volume on civic engagement with what's touted as the biggest Party at the Polls program yet. With almost 700 get-togethers riffing across the U.S.,...

Continue Reading
Auburn's Education Fair Bridges Students and Schools

Updated Category News Views 2

Bridging the Gap: Students Meet Future Employers Walking into Auburn University’s College of Education building, you'd get hit with the buzz of anticipation wafting through the halls. The Fall Education Interview Day was in full swing. With over 35 employers in attendance, this event wasn’t just any run-of-the-mill career fair. This was a chance for students to lock...

Continue Reading
Genedata's AI Push: A Biotech Game-Changer?

Updated Category News Views 12

A Glimpse into Genedata's Bold AI Integration So, here's a heck of an ambitious move in the biotech sphere with Genedata dropping the news about their integration of NVIDIA's BioNeMo AI models into their R&D workflows. These folks at Genedata are really riding the tech wave, offering up the new RFD4-Proteina release in what they call 'binder design' for biologics...

Continue Reading
TTM Technologies Faces Legal Scrutiny Amidst Stock Drop

Updated Category News Views 3

TTM Technologies: A Hard Hit and Legal Turmoil When the stock market throws a punch, not everyone sees it coming. Here we are with TTM Technologies (NASDAQ: TTMI) witnessing a sudden plunge that has left many investors scrambling. Just when the company seemed to have its sails set, the wind shifted direction, taking a chunk out of its market value as it reported its...

Continue Reading
Montega Kicks Off Agilyx Sponsored Equity Research

Updated Category News Views 2

A Fresh Take on Agilyx's Market Standing Alright, folks. Agilyx ASA just got a new ticket for the analytical rodeo as Montega AG dives into sponsored equity research on the company. For those who aren't fluent in the arcane dialect of stock enthusiasts like yours truly, this means Agilyx now has another sharp set of eyes evaluating their every move, and let me tell you,...

Continue Reading
Critical Questions to Ask When Buying Life Insurance

Updated Category News Views 1

Getting Under the Hood of Life Insurance Alright, so you're thinking about life insurance. Not exactly a day at the beach, but it’s one of those crucial life things to nail down. Paula Miller, a savvy insurance pro, walks through what to consider before you just slap down a signature and hope for the best. The Basics: Policy Types and Coverage Life insurance can be as...

Continue Reading
Travel FOMO Trumps High Costs: Family Drives Demand

Updated Category News Views 7

Sky-High Travel Costs? No Problem Who'd have thought folks would still be packing their bags with travel costs through the roof? Well, it seems like Americans have their priorities straight—or not, depending on how you look at it. Travel insurance provider Squaremouth reports insured trips are up 12.9% year over year, even with the average trip costing a whopping...

Continue Reading
Microtubule Defects Revealed: Impacts on Cancer Treatment

Updated Category News Views 5

Peering into the Heart of Microtubules Ever squint at a tapestry, only to find a rogue thread ruining the pattern? Well, that’s somewhat what scientists at Kanazawa University have found with microtubules, those tiny rods in our cells that usually keep it all together. Using some pretty fancy tech called high-speed atomic force microscopy, these folks peered into the...

Continue Reading

Top 5 Most Recently Viewed Articles

Canada's Immigration Policy Change: Balancing Growth and Services

Updated Category News Views 198

Canada's Shift in Immigration Strategy In a significant policy announcement, the government of Canada has decided to cut back on immigration numbers. Prime Minister Justin Trudeau emphasized the need for this adjustment in response to the growing pressures on housing and social services, a situation exacerbated by the pandemic's aftermath. The Public's Changing...

Continue Reading
Ryder System's Impressive Q3 Results and Analyst Concerns

Updated Category News Views 58

Ryder System Reports Strong Q3 Earnings Ryder System Inc. (NYSE: R) has released its earnings report for the third quarter, showcasing a performance that surpassed analysts' expectations. The transportation and logistics firm reported adjusted earnings per share of $3.44, marginally exceeding the anticipated $3.41. While the revenue reached $3.2 billion, it slightly fell...

Continue Reading
Jericho Project Celebrates NYSE Milestone with New Housing

Updated Category News Views 274

Jericho Project Rings Closing Bell at NYSE in Celebration of Housing In a remarkable event at the New York Stock Exchange, Jericho Project celebrated the opening of Logan Fountain, a new supportive housing initiative that aims to help individuals and families experiencing homelessness. Tori Lyon, the organization's CEO, proudly rang the closing bell, marking a significant...

Continue Reading
RBC Warns of Pennon Group's Financial Challenges Ahead

Updated Category News Views 157

RBC Downgrades Pennon Group's Stock Outlook RBC Capital has recently revised its outlook on Pennon Group Plc (LSE:PNN) (OTC:PEGRF), downgrading the utility company's rating from Outperform to Sector Perform. The investment firm has also lowered its price target for the company's stock from GBP7.25 to GBP6.75. This decision stems from growing worries about the company's...

Continue Reading
RPM International's Impressive Margin Performance Fuels Optimism

Updated Category News Views 98

RPM International Sees Target Price Increase Amid Strong Earnings Recently, Seaport Global Securities reviewed its evaluation of RPM International (NYSE: RPM), boosting its stock price target from $140 to $150. This change comes after RPM's first-quarter earnings, which not only met but exceeded market expectations, highlighting the company's strength even in challenging...

Continue Reading